Search

Your search keyword '"Puodziukynas, Aras"' showing total 23 results
Start Over Author "Puodziukynas, Aras"
23 results on '"Puodziukynas, Aras"'

8. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)

Author

Brugada, Josep, Katritsis, Demosthenes, Arbelo, Elena, Arribas, Fernando, Bax, Jeroen, Blomström-Lundqvist, Carina, Calkins, Hugh, Corrado, Domenico, Deftereos, Spyridon, Diller, Gerhard-Paul, Gomez-Doblas, Juan, Gorenek, Bulent, Grace, Andrew, Ho, Siew Yen, Kaski, Juan-Carlos, Kuck, Karl-Heinz, Lambiase, Pier David, Sacher, Frederic, Sarquella-Brugada, Georgia, Suwalski, Piotr, Zaza, Antonio, De Potter, Tom, Sticherling, Christian, Basso, Cristina, Bocchiardo, Mario, Budts, Werner, Dobrev, Dobromir, Gevaert, Sofie, Heidbuchel, Hein, Kanagaratnam, Prapa, Kriebel, Thomas, Lancellotti, Patrizio, Lopatin, Yury, Merkely, Béla, Paul, Thomas, Pavlović, Nikola, Potpara, Tatjana, Scherr, Daniel, Zeppenfeld, Katja, Windecker, Stephan, Aboyans, Victor, Baigent, Colin, Collet, Jean-Philippe, Dean, Veronica, Delgado, Victoria, Fitzsimons, Donna, Gale, Chris, Grobbee, Diederick, Halvorsen, Sigrun, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo, Landmesser, Ulf, Leclercq, Christophe, Lettino, Maddalena, Lewis, Basil, Merkely, Bela, Mueller, Christian, Petersen, Steffen, Petronio, Anna Sonia, Richter, Dimitrios, Roffi, Marco, Shlyakhto, Evgeny, Simpson, Iain, Sousa-Uva, Miguel, Touyz, Rhian, Amara, Walid, Grigoryan, Svetlana, Podczeck-Schweighofer, Andrea, Chasnoits, Alexandr, Vandekerckhove, Yves, Sokolovich, Sekib, Traykov, Vassil, Skoric, Bosko, Papasavvas, Elias, Kautzner, Josef, Riahi, Sam, Kampus, Priit, Parikka, Hannu, Piot, Olivier, Etsadashvili, Kakhaber, STELLBRINK, CHRISTOPH, Manolis, Antonis, Csanádi, Zoltán, Gudmundsson, Kristjan, Erwin, John, Barsheshet, Alon, De Ponti, Roberto, Abdrakhmanov, Ayan, Jashari, Haki, Lunegova, Olga, Jubele, Kristine, Refaat, Marwan, Puodziukynas, Aras, Groben, Laurent, Grosu, Aurel, Pavlovic, Nikola, Ibtissam, Fellat, Trines, Serge, Poposka, Lidija, Haugaa, Kristina, Kowalski, Oskar, Cavaco, Diogo, Dobreanu, Dan, Mikhaylov, Evgeny, Zavatta, Marco, Nebojša, Mujović, Hlivak, Peter, Ferreira-Gonzalez, Ignacio, Juhlin, Tord, Reichlin, Tobias, Haouala, Habib, Akgun, Taylan, Gupta, Dhiraj, IHU-LIRYC, and Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux]

Subjects
Tachycardia, pre-excitation, congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, focal, [SDV]Life Sciences [q-bio], Cardiology, Guidelines, 030204 cardiovascular system & hematology, tachycardia, arrhythmia, ablation, atrioventricular, flutter, junctional, macro–re-entrant, nodal, re-entrant, supraventricular, Electrocardiography, 03 medical and health sciences, 0302 clinical medicine, Tachycardia, Supraventricular, medicine, Humans, cardiovascular diseases, ComputingMilieux_MISCELLANEOUS, reproductive and urinary physiology, Task force, business.industry, Arrhythmias, Cardiac, 030229 sport sciences, medicine.disease, 3. Good health, EBSTEIN ANOMALY, embryonic structures, Emergency medicine, Catheter Ablation, cardiovascular system, Re entrant, Supraventricular tachycardia, medicine.symptom, Cardiology and Cardiovascular Medicine, business
Abstract

2019 ESC Guidelines for the management of patients with supraventricular tachycardia : The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)

Published
2019
Full Text
View/download PDF

9. Major Bleeding of Transjugular Native Kidney Biopsies. A French Nationwide Cohort Study

Author

Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis, Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan, La Meir, Mark, Lane, Deirdre, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory, Pinto, Fausto, Thomas, G Neil, Valgimigli, Marco, van Gelder, Isabelle, van Putte, Bart, Watkins, Caroline, Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, a John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry, Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Fitzsimons, Donna, Folliguet, Thierry, Gale, Chris, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo, Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil, Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia, Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto, Petersen, Steffen, Piccini, Jonathan, Popescu, Bogdan, Pürerfellner, Helmut, Richter, Dimitrios, Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate, Simpson, Iain, Shlyakhto, Evgeny, Sinner, Moritz, Steffel, Jan, Sousa-Uva, Miguel, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian, Neil Thomas, G, Delassi, Tahar, Sisakian, Hamayak, Chasnoits, Alexandr, Pauw, Michel De, Smajić, Elnur, Shalganov, Tchavdar, Avraamides, Panayiotis, Kautzner, Josef, Gerdes, Christian, Alaziz, Ahmad Abd, Kampus, Priit, Raatikainen, Pekka, Boveda, Serge, Papiashvili, Giorgi, Vassilikos, Vassilios, Csanádi, Zoltán, Arnar, David, Galvin, Joseph, Barsheshet, Alon, Caldarola, Pasquale, Rakisheva, Amina, Bytyçi, Ibadete, Kerimkulova, Alina, Kalejs, Oskars, Njeim, Mario, Puodziukynas, Aras, Groben, Laurent, Sammut, Mark, Grosu, Aurel, Boskovic, Aneta, Moustaghfir, Abdelhamid, Groot, Natasja De, Poposka, Lidija, Anfinsen, Ole-Gunnar, Mitkowski, Przemyslaw, Cavaco, Diogo Magalhães, Siliste, Calin, Mikhaylov, Evgeny, Bertelli, Luca, Kojic, Dejan, Hatala, Robert, Fras, Zlatko, Arribas, Fernando, Juhlin, Tord, Sticherling, Christian, Abid, Leila, Atar, Ilyas, Sychov, Oleg, Bates, Matthew, Zakirov, Nodir, Halimi, Jean-Michel, Gatault, Philippe, Longuet, Hélène, Barbet, Christelle, Goumard, Annabelle, Gueguen, Juliette, Goin, Nicolas, Sautenet, Bénédicte, Herbert, Julien, Bisson, Arnaud, Universität Leipzig [Leipzig], University of Belgrade [Belgrade], Leiden University Medical Center (LUMC), Uppsala University, Università degli Studi di Modena e Reggio Emilia, Colentina University Hospital, University of Medicine and Pharmacy 'Carol Davila' Bucharest (UMPCD), CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Éducation Éthique Santé EA 7505 (EES), Université de Tours (UT), National and Kapodistrian University of Athens (NKUA), Université d'Athènes (UOA), Attikon University Hospital, The Royal Melbourne Hospital, University of Liverpool, San Gerardo Hospital of Monza, Aalborg University [Denmark] (AAU), Universidade Nova de Lisboa = NOVA University Lisbon (NOVA), Faculdade de Medicina [Lisboa], Universidade de Lisboa (ULISBOA), Hospital de Santa Maria [Lisboa], Service de néphrologie et immunologie clinique [CHRU Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, and Université de Nantes (UN)-Université de Nantes (UN)

Subjects
medicine.medical_specialty, Framingham Risk Score, Percutaneous, business.industry, medicine.medical_treatment, kidney biopsy, Retrospective cohort study, Odds ratio, Lower risk, medicine.disease, transjugular, Nephrectomy, Surgery, [SHS]Humanities and Social Sciences, bleeding score, Hematoma, percutaneous, Nephrology, Clinical Research, medicine, epidemiology, business, ComputingMilieux_MISCELLANEOUS, Cohort study
Abstract

Introduction The risk of bleeding associated with transjugular kidney biopsies is unclear, and which patients are the best candidates for this route is unknown. Methods This was a retrospective cohort study comparing proportion of bleeding associated with transjugular versus percutaneous native kidney biopsies in all patients in France in the 2010–2019 period. Major bleeding at day 8 (i.e., blood transfusions, hemorrhage/hematoma, angiographic intervention, nephrectomy) and risk of death at day 30 were assessed, and we used a bleeding risk score initially developed for the percutaneous route. Results Our analysis included 60,331 patients (transjugular route: 5305; percutaneous route: 55,026 patients). The observed proportion of major bleeding varied widely (transjugular vs. percutaneous): 0.4% versus 0.5% for the lowest risk scores (0–4) to 19.1% versus 30.8% for the highest risk scores (≥35). Transjugular was more frequently used than percutaneous route (39% vs. 24%) when the risk score was ≥20 (15,133/60,331; 25% of all patients). Transjugular was associated with a lower risk of major bleeding than percutaneous route in multivariate analyses (odds ratio [OR]: 0.88 [0.78–0.99]), especially for scores ≥20 (OR: 0.83 [0.72–0.96], (i.e., 25% of patients). Major bleeding was associated with an increased risk of death both for transjugular (OR: 1.77 [1.00–3.14]) and percutaneous (OR: 1.80 [1.43–2.28]) routes. Conclusions The transjugular route is independently associated with a lower risk of bleeding than the percutaneous route, especially in high-risk patients identified by a preprocedure risk score ≥20 (i.e., 25% of patients). Major bleeding is associated with an increased risk of death for both routes., Graphical abstract

Published
2021
Full Text
View/download PDF

10. Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.

Author

Ardashev, Andrey, primary, Oseroff, Oscar, additional, Sansalone, Rodolfo, additional, Zhelyakov, Evgeny G, additional, Cappato, Riccardo, additional, Snezhitskiy, Viktor, additional, Kanorskii, Sergey, additional, Abzalieva, Symbat, additional, Belenkov, Yury, additional, Karpenko, Yury, additional, Puodziukynas, Aras, additional, Sayganov, Sergey A, additional, Santini, Luca, additional, Speranza, Ricardo, additional, Yakovleva, Marina, additional, and Kolotsey, Ludmila, additional

Published
2020
Full Text
View/download PDF

12. Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic

Author

Belenkov, Yu. N., primary, Snezhitskiy, V. A., additional, Ardashev, A. V., additional, Abzaliyeva, S. A., additional, Cappato, Riccardo, additional, Karpenko, J. I., additional, Konev, A. V., additional, Nechepurenko, A. A., additional, Raviele, Antonio, additional, Puodziukynas, Aras, additional, Sayganov, S. A., additional, Santini, Luca, additional, Shugaev, P. L., additional, Yakovleva, M. V., additional, Zateyshchikov, D. A., additional, Yuzvinkevitch, S. A., additional, and Zhelyakov, E. G., additional

Published
2020
Full Text
View/download PDF

13. Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)

Author

Moya, Angel, Sutton, Richard, Ammirati, Fabrizio, Blanc, Jean-Jacques, Brignole, Michele, Dahm, Johannes B., Deharo, Jean-Claude, Gajek, Jacek, Gjesdal, Knut, Krahn, Andrew, Massin, Martial, Pepi, Mauro, Pezawas, Thomas, Granell, Ricardo Ruiz, Sarasin, Francois, Ungar, Andrea, van Dijk, J Gert, Walma, Edmond P., Wieling, Wouter, Abe, Haruhiko, Benditt, David G., Decker, Wyatt W., Grubb, Blair P., Kaufmann, Horacio, Morillo, Carlos, Olshansky, Brian, Parry, Steve W., Sheldon, Robert, Shen, Win K., Vahanian, Alec, Auricchio, Angelo, Bax, Jeroen, Ceconi, Claudio, Dean, Veronica, Filippatos, Gerasimos, Funck-Brentano, Christian, Hobbs, Richard, Kearney, Peter, McDonagh, Theresa, McGregor, Keith, Popescu, Bogdan A., Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Vardas, Panos, Widimsky, Petr, Auricchio, Angelo, Acarturk, Esmeray, Andreotti, Felicita, Asteggiano, Riccardo, Bauersfeld, Urs, Bellou, Abdelouahab, Benetos, Athanase, Brandt, Johan, Chung, Mina K., Cortelli, Pietro, Da Costa, Antoine, Extramiana, Fabrice, Ferro, José, Gorenek, Bulent, Hedman, Antti, Hirsch, Rafael, Kaliska, Gabriela, Kenny, Rose Anne, Kjeldsen, Keld Per, Lampert, Rachel, Mølgard, Henning, Paju, Rain, Puodziukynas, Aras, Raviele, Antonio, Roman, Pilar, Scherer, Martin, Schondorf, Ronald, Sicari, Rosa, Vanbrabant, Peter, Wolpert, Christian, and Zamorano, Jose Luis

Published
2009

14. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) : the Task Force for the diagnosis and management of atrialfibrillation of the European Society of Cardiology (ESC) : developed with the special contribution of the European HeartRhythm Association (EHRA) of the ESC

Author

Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen J., Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E., Fauchier, Laurent, Petersen, Steffen E., Piccini, Jonathan P., Popescu, Bogdan A., Pürerfellner, Helmut, Richter, Dimitrios J., Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate B., Simpson, Iain A., Raatikainen, Pekka, Shlyakhto, Evgeny, Sinner, Moritz F., Steffel, Jan, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian M., Windecker, Stephan, Baigent, Colin, Collet, Jean-Philippe, Dean, Veronica, Boveda, Serge, Fitzsimons, Donna, Gale, Chris P., Grobbee, Diederick E., Halvorsen, Sigrun, Lung, Bernard, Jüni, Peter, Petronio, Anna Sonia, Sousa Uva, Miguel, Delassi, Tahar, Sisakian, Hamayak S., Papiashvili, Giorgi, Chasnoits, Alexandr, De Pauw, Michel, Smajić, Elnur, Shalganov, Tchavdar, Avraamides, Panayiotis, Kautzner, Josef, Gerdes, Christian, Alaziz, Ahmad Abd, Kampus, Priit, Vassilikos, Vassilios P., Csanádi, Zoltán, Arnar, David O., Galvin, Joseph, Barsheshet, Alon, Caldarola, Pasquale, Rakisheva, Amina, Filippatos, Gerasimos, Bytyçi, Ibadete, Kerimkulova, Alina, Kalejs, Oskars, Njeim, Mario, Puodziukynas, Aras, Groben, Laurent, Sammut, Mark A., Grosu, Aurel, Boskovic, Aneta, Moustaghfir, Abdelhamid, Kalman, Jonathan M., de Groot, Natasja, Poposka, Lidija, Anfinsen, Ole-Gunnar, Mitkowski, Przemyslaw P., Cavaco, Diogo, Siliste, Calin, Mikhaylov, Evgeny N., Bertelli, Luca, Kojic, Dejan, Hatala, Robert, La Meir, Mark, Fras, Zlatko, Arribas, Fernando, Juhlin, Tord, Sticherling, Christian, Abid, Leila, Atar, Ilyas, Sychov, Oleg, Bates, Matthew G. D., Zakirov, Nodir U., Lane, Deirdre A., Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y. H., Pinto, Fausto J., Thomas, G. Neil, Valgimigli, Marco, Van Gelder, Isabelle C., Van Putte, Bart P., Watkins, Caroline L., Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, A. John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry J. G. M., Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Folliguet, Thierry, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo A., Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil S., Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia V., Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto F. E., and Repositório da Universidade de Lisboa

Subjects
Rate control, AF surgery, Guidelines, Upstream therapy, Recommendations, Left atrial appendage occlusion, Atrial fibrillation, Pulmonary vein isolation, Left atrial ablation, Antiarrhythmic drugs, Cardioversion, Stroke, Anticoagulation, Vitamin K antagonists, Screening, Non-vitamin K antagonist oral anticoagulants, Rhythm control, Catheter ablation, ABC pathway
Abstract

© 2020 European Society of Cardiology. All rights reserved., Atrial fibrillation (AF) poses significant burden to patients, physicians, and healthcare systems globally. Substantial research efforts and resources are being directed towards gaining detailed information about the mechanisms underlying AF, its natural course and effective treatments (see also the ESC Textbook of Cardiovascular Medicine: CardioMed) and new evidence is continuously generated and published. The complexity of AF requires a multifaceted, holistic, and multidisciplinary approach to the management of AF patients, with their active involvement in partnership with clinicians. Streamlining the care of patients with AF in daily clinical practice is a challenging but essential requirement for effective management of AF. In recent years, substantial progress has been made in the detection of AF and its management, and new evidence is timely integrated in this third edition of the ESC guidelines on AF. The 2016 ESC AF Guidelines introduced the concept of the five domains to facilitate an integrated structured approach to AF care and promote consistent, guideline-adherent management for all patients. The Atrial Fibrillation Better Care (ABC) approach in the 2020 ESC AF Guidelines is a continuum of this approach, with the goal to further improve the structured management of AF patients, promote patient values, and finally improve patient outcomes.

Published
2020

16. Guía de práctica clínica para el diagnóstico y manejo del síncope (versión 2009)

Author

Moya, Ángel, Sutton, Richard, Ammirati, Fabrizio, Blanc, Jean-Jacques, Brignole, Michele, Dahm, Johannes B., Deharo, Jean-Claude, Gajek, Jacek, Gjesdal, Knut, Krahn, Andrew, Massin, Martial, Pepi, Mauro, Pezawas, Thomas, Granell, Ricardo Ruiz, Sarasin, Francois, Ungar, Andrea, Gert van Dijk, J., Walma, Edmond P., Wieling, Wouter, Abe, Haruhiko, Benditt, David G., Decker, Wyatt W., Grubb, Blair P., Kaufmann, Horacio, Morillo, Carlos, Olshansky, Brian, Parry, Steve W., Sheldon, Robert, Shen, Win K., Vahanian, Alec, Auricchio, Angelo, Bax, Jeroen, Ceconi, Claudio, Dean, Veronica, Filippatos, Gerasimos, Funck-Brentano, Christian, Hobbs, Richard, Kearney, Peter, McDonagh, Theresa, McGregor, Keith, Popescu, Bogdan A., Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Vardas, Panos, Widimsky, Petr, Acarturk, Esmeray, Andreotti, Felicita, Asteggiano, Riccardo, Bauersfeld, Urs, Bellou, Abdelouahab, Benetos, Athanase, Brandt, Johan, Chung, Mina K., Cortelli, Pietro, Costa, Antoine Da, Extramiana, Fabrice, Ferro, José, Gorenek, Bulent, Hedman, Antti, Hirsch, Rafael, Kaliska, Gabriela, Kenny, Rose Anne, Kjeldse, Keld Per, Lampert, Rachel, Mølgard, Henning, Paju, Rain, Puodziukynas, Aras, Raviele, Antonio, Roman, Pilar, Scherer, Martin, Schondorf, Ronald, Sicari, Rosa, Vanbrabant, Peter, Wolpert, Christian, and Zamorano, José Luis

Published
2009
Full Text
View/download PDF

17. Heart rate variability after radiofrequency ablation of epicardial ganglionated plexuses on the ovine left atrium

Author

Kviesulaitis, Vilius, primary, Puodziukynas, Aras, additional, Pauza, Dainius Haroldas, additional, Zabiela, Vytautas, additional, Kazakevicius, Tomas, additional, Vaitkevicius, Raimundas, additional, Diržinauskas, Evaldas, additional, Semaška, Vytenis, additional, Strazdas, Antanas, additional, Unikaite, Ruta, additional, Rysevaite, Kristina, additional, Pauziene, Neringa, additional, and Zaliunas, Remigijus, additional

Published
2017
Full Text
View/download PDF

18. Predictors of positive response to cardiac resynchronization therapy

Author

Rinkuniene, Diana, primary, Bucyte, Silvija, additional, Ceseviciute, Kristina, additional, Abramavicius, Silvijus, additional, Baronaite-Dudoniene, Kristina, additional, Laukaitiene, Jolanta, additional, Kazakevicius, Tomas, additional, Zabiela, Vytautas, additional, Sileikis, Vytautas, additional, Puodziukynas, Aras, additional, and Jurkevicius, Renaldas, additional

Published
2014
Full Text
View/download PDF

20. Changes of electrophysiological parameters in patients with atrial flutter.

Author

Zaliaduonyte-Peksiene D, Kazakevicius T, Zabiela V, Sileikis V, Vaiciulis R, Virketis M, and Puodziukynas A

Subjects
Aged, Atrial Flutter diagnostic imaging, Atrial Flutter surgery, Catheter Ablation, Data Interpretation, Statistical, Echocardiography, Electrocardiography, Electrophysiology, Female, Heart Atria anatomy & histology, Humans, Male, Middle Aged, Radiography, Refractory Period, Electrophysiological, Atrial Flutter physiopathology, Heart Atria physiopathology
Abstract

Objectives: The aim of the study was to study some anatomic and electrophysiological features of the right atrium, related to the presence of atrial flutter., Materials and Methods: A total 23 patients with type I atrial flutter and 22 patients without atrial flutter were studied. Right atrium size was assessed using echocardiography before intracardiac examination and radiofrequency ablation., Results: Effective refractory periods of coronary sinus, high right atrium, low right atrium were different comparing with the control group (P<0.05). A stimulus-response time between high right atrium and low right atrium positions in anterograde and retrograde ways, an impulse propagation speed along the lateral wall of the right atrium were statistically different comparing both groups (P<0.05). There was a significant correlation among effective refractory periods measured in different sites of the right atrium (r2=0.64, 0.44, 0.44, respectively). All measured effective refractory periods also correlated with stimulus-response time in anterograde way (P<0.05) and impulse propagation speed (P<0.05). Right atrium dimensions were significantly larger in atrial flutter group. There was no correlation between the right atrium dimensions and measured electrophysiological parameters in both groups., Conclusions: The presence of atrial flutter associates with diffuse alterations of the right atrium, but not the focal or single changes of refractoriness.

Published
2007

21. Idiopathic ventricular tachycardia in children: curative therapy with radiofrequency ablation.

Author

Baksiene D, Sileikiene R, Sileikis V, Kazakevicius T, Zabiela V, Zebiene M, and Puodziukynas A

Subjects
Adolescent, Age Factors, Bundle-Branch Block diagnosis, Bundle-Branch Block physiopathology, Child, Child, Preschool, Echocardiography, Electrocardiography, Electrophysiology, Female, Follow-Up Studies, Humans, Male, Safety, Tachycardia, Ventricular diagnosis, Tachycardia, Ventricular physiopathology, Time Factors, Treatment Outcome, Catheter Ablation, Tachycardia, Ventricular surgery
Abstract

Unlabelled: Idiopathic ventricular tachycardia is a rare condition, and there is a lack of clear guidelines for the necessity and indications for prophylactic antiarrhythmic or curative treatment. The aim of this study was to review the clinical picture of idiopathic ventricular tachycardia and evaluate the efficacy and safety of radiofrequency ablation therapy in children., Material and Methods: The subjects of this study were 16 children with idiopathic ventricular tachycardia. The mean age at onset of idiopathic ventricular tachycardia was 12 years. All patients underwent electrophysiological examination. Nonfluoroscopic mapping technology (Carto) was used in one case. Radiofrequency ablation was performed in all children (mean duration of follow-up was 46 months)., Results: Six children with idiopathic ventricular tachycardia were free of symptoms. Palpitation was the only complain in four patients, and six patients presented with symptoms of circulatory disorder (the tendency of the higher rate of ventricular tachycardia and more premature contractions and episodes of ventricular tachycardia in one day were noticed in five of them). All children after radiofrequency ablation were alive, and only one complication (complete right bundle branch block) occurred. Success at last follow-up included five children with left and six with right idiopathic ventricular tachycardia., Conclusions: Catheter ablation seems a promising therapeutic option with the outlook possible of the idiopathic ventricular tachycardia in children. It is safe enough and should be considered as the therapy of choice even in children without of symptoms if they wish to live active social and physical life.

Published
2007

22. Alterations of platelet aggregation while treating cardiac arrhythmias with radiofrequency ablation.

Author

Kozlovaite V, Grybauskas P, Cimbolaityte J, Mongirdiene A, Puodziukynas A, Sileikis V, Kazakevicius T, and Zabiela V

Subjects
Adenosine Diphosphate pharmacology, Adrenergic Agonists pharmacology, Adult, Data Interpretation, Statistical, Epinephrine pharmacology, Follow-Up Studies, Humans, Middle Aged, Postoperative Period, Time Factors, Arrhythmias, Cardiac blood, Arrhythmias, Cardiac surgery, Catheter Ablation, Platelet Aggregation drug effects
Abstract

Objective: To find out if radiofrequency ablation as method of treatment of cardiac arrhythmia influences platelet aggregation and if intensity of this process depends on the number of radiofrequency ablation episodes for one patient., Material and Methods: We analyzed platelet aggregation before, right after and in 24 hours after radiofrequency ablation in whole blood and platelet rich plasma in 39 cases with cardiac arrhythmias. Adenosine diphosphate and adrenaline were used for aggregation induction. Three groups of patients were formed based on the number of radiofrequency ablation episodes: A-- <10, B--10-20, C-- >20 for one patient., Results: We detected a decrease in spontaneous, adenosine diphosphate and adrenaline induced platelet aggregation in plasma right after radiofrequency ablation, and also the same tendency was noted in adenosine diphosphate induced aggregation in whole blood. In 24 hours after radiofrequency ablation platelet aggregation tended to return to pre-radiofrequency ablation levels. Based on the number of radiofrequency ablation episodes we detected significant changes in spontaneous and adrenaline-induced aggregation in plasma. In group A adrenaline induced aggregation after radiofrequency ablation increased by 0.4%, in group B it decreased by 15.7% and in group C it decreased by 19.4% from pre-radiofrequency ablation level (p<0.05, between groups A and C). Spontaneous platelet aggregation after radiofrequency ablation decreased in group A 41.9%, in group B--20.8% and in group C--18.4% from pre-radiofrequency ablation level (p<0.05 between groups A and C). The greater decrease in adenosine diphosphate induced aggregation in plasma and in whole blood was detected in the group with larger number of radiofrequency ablation episodes., Conclusions: This study found that platelet aggregation decreased in plasma and in whole blood after radiofrequency ablation. And this alteration was significant in groups B and C, when the number of radiofrequency ablation episodes were >10. In 24 hours platelet aggregation increased again to pre- radiofrequency ablation level.

Published
2004

23. [Atrial fibrillation: rhythm control versus rate control? (New evidences from clinical trials)].

Author

Auskalniene R, Kavoliūniene A, and Puodziukynas A

Subjects
Age Factors, Aged, Aged, 80 and over, Anti-Arrhythmia Agents administration & dosage, Anti-Arrhythmia Agents therapeutic use, Anticoagulants administration & dosage, Anticoagulants therapeutic use, Atrial Fibrillation complications, Atrial Fibrillation drug therapy, Atrial Fibrillation mortality, Atrial Fibrillation physiopathology, Atrial Fibrillation surgery, Catheter Ablation, Clinical Trials as Topic, Electric Countershock, Female, Follow-Up Studies, Heart Rate, Humans, Male, Multicenter Studies as Topic, Pacemaker, Artificial, Randomized Controlled Trials as Topic, Risk Factors, Time Factors, Atrial Fibrillation therapy
Abstract

One of the fundamental questions in the management of atrial fibrillation is whether cardioversion should be attempted. Studies have compared rate control with rhythm control strategies. Rhythm control has not been shown to be superior to rate control (with chronic anticoagulation) in reducing morbidity and mortality and may be inferior in some patient subgroups to rate control. Whether these results can be extrapolated to longer time periods than the trial duration (approximately 3.5 years) is not known. The purpose of this article is to discuss some important aspects of atrial fibrillation and to review recent developments in the management of this condition.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results